Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AZN
Recent news which mentions AZN
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 12, 2022
Tickers
ACER
APTX
AZN
GH
Tags
AZN
News
General
From
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
Large Cap
Briefs
From
Benzinga
This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%
August 10, 2022
Tickers
AZN
ZNTL
Tags
Health Care
Briefs
AZN
From
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Tickers
ARCT
AXSM
AYTU
AZN
Tags
General
IONS
AZN
From
Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Benzinga
DSKYF
General
From
Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
Tickers
AZN
CINC
ENDP
HCM
Tags
Biotech Catalysts / EOD Summary
ZLAB
Biotech
From
Benzinga
AstraZeneca (AZN) Announces Approval of ENHERTU (HER2-low Metastatic Breast Cancer) in the United States
August 08, 2022
Tickers
AZN
Tags
Analyst Rating
AZN
News
From
Best Stocks
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
August 08, 2022
Tickers
AZN
MRNA
PFE
VALN
Tags
Small Cap
Biotech
Market News
From
Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
Tickers
AZN
EVO
KTTA
MRK
Tags
Biotech
Market News
PFE
From
Benzinga
AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting
August 08, 2022
Tickers
AZN
AZNCF
HCM
Tags
Health Care
General
News
From
Benzinga
3 Unstoppable Stocks That Don't Care About the Bear Market
August 07, 2022
Tickers
ABBV
AZN
BMY
Tags
BMY
AZN
Recent Press Releases
From
Motley Fool
Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal
August 05, 2022
Tickers
ABBV
AZN
BMY
JNJ
Tags
PFE
LLY
MRK
From
MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
Tickers
ARQT
ATXS
AZN
MRK
Tags
ATXS
PLSE
Biotech Catalysts / EOD Summary
From
Benzinga
Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs
August 04, 2022
Tickers
AZN
AZNCF
LLY
PIRS
Tags
PIRS
LLY
Health Care
From
Benzinga
AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy
August 04, 2022
Tickers
AZN
MRK
Tags
MRK
Health Care
Market News
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
VIR
ADAP
VYGR
From
Benzinga
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
August 02, 2022
Tickers
AZN
EBS
JNJ
Tags
Small Cap
Market News
Biotech
From
Benzinga
Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody
August 01, 2022
Tickers
AVTX
AZN
Tags
Benzinga
Movers
General
From
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Tickers
ALXO
ARQT
AZN
BEAM
Tags
ELDN
TXMD
KZIA
From
Benzinga
AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer
August 01, 2022
Tickers
AZN
AZNCF
IPHA
Tags
Benzinga
Movers
General
From
Benzinga
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
July 31, 2022
Tickers
AMGN
AZN
Tags
Market News
Recent Press Releases
AMGN
From
Motley Fool
3 Stocks We Think Could Beat the Market in the Second Half of 2022
July 30, 2022
Tickers
ABBV
AZN
JNJ
Tags
AZN
Recent Press Releases
ABBV
From
Motley Fool
AstraZeneca Drops Moderna-Partnered, Phase 2 Heart Disease Drug Candidate
July 29, 2022
Tickers
AZN
AZNCF
MRNA
Tags
Benzinga
General
AZN
From
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
Biotech
IMGN
ICVX
From
Benzinga
Recap: AstraZeneca Q2 Earnings
July 29, 2022
Tickers
AZN
Tags
News
AZN
Earnings
From
Benzinga
Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29
July 29, 2022
Tickers
AAPL
AMZN
AZN
BABA
Tags
TCEHY
MSFT
AZN
From
Benzinga
AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance
July 29, 2022
Tickers
AZN
AZNCF
Tags
Guidance
Health Care
General
From
Benzinga
Earnings Scheduled For July 29, 2022
July 29, 2022
Tickers
AB
ABBV
ABR
ABTX
Tags
GRC
FHB
LYB
From
Benzinga
$100 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today
July 28, 2022
Tickers
AZN
Tags
AZN
News
Earnings
From
Benzinga
FDA Accepts AstraZeneca's Submission For Low Breast Cancer Candidate Under Priority Review
July 25, 2022
Tickers
AZN
Tags
Market News
Biotech
Health Care
From
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.